A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas
暂无分享,去创建一个
Jean Mosser | Philippe Menei | Marc Aubry | Marie de Tayrac | J. Mosser | M. Aubry | V. Quillien | P. Menei | M. Galibert | T. Lesimple | A. Hamlat | Véronique Quillien | A. Etcheverry | S. Saïkali | Stephan Saïkali | Amandine Etcheverry | Cyrille Surbled | Frédérique Guénot | Marie-Dominique Galibert | Abderrahmane Hamlat | Thierry Lesimple | Cyrille Surbled | M. de Tayrac | Frédérique Guénot
[1] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[2] Michael M Lieber,et al. PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] T. Golub,et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.
[4] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[5] A. Brodbelt,et al. Molecular Diagnostics , 2011, Human Genomics.
[6] Rainer Breitling,et al. A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments , 2008, Bioinform..
[7] S. Ishii,et al. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas , 2008, Cancer science.
[8] C. Mignogna,et al. Chromatin assembly factor‐1 (CAF‐1)‐mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? , 2007, Histopathology.
[9] Yusuke Nakamura,et al. HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres , 2009, Cell.
[10] S. Horvath,et al. Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.
[11] Frank M. Sacks,et al. IDH 1 and IDH 2 Mutations in Gliomas , 2009 .
[12] Madan Arora,et al. Primary brain tumors in adults. , 2008, American family physician.
[13] K. Aldape,et al. A multigene predictor of outcome in glioblastoma. , 2010, Neuro-oncology.
[14] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[15] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[16] A. Bresnick,et al. Integrin α6β4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin* , 2009, Journal of Biological Chemistry.
[17] J. Klijanienko,et al. Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells , 2004, Cancer Research.
[18] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[19] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[20] K. Hoang-Xuan,et al. Primary brain tumours in adults , 2003, The Lancet.
[21] J. Mosser,et al. Integrative genome‐wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression , 2009, Genes, chromosomes & cancer.
[22] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[23] F. Ducray,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[24] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[25] R. Schwartz,et al. Primary brain tumors in adults. , 1992, Seminars in ultrasound, CT, and MR.
[26] K. Aldape,et al. Molecular predictors in glioblastoma: toward personalized therapy. , 2008, Archives of neurology.
[27] J. Nelson,et al. The endothelin axis: emerging role in cancer , 2003, Nature Reviews Cancer.
[28] David N Louis,et al. Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.
[29] Tom C. Freeman,et al. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data , 2008, Molecular Cancer Therapeutics.
[30] Yuri Kotliarov,et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. , 2009, Cancer research.
[31] Jayant P. Menon,et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.
[32] Rainer Breitling,et al. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..
[33] J. Yates,et al. Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP , 2009, Cell.
[34] D. Nelson,et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.
[35] D. Botstein,et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] Yusuke Nakamura,et al. Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. , 2007, Cancer research.
[37] S. Lê,et al. BMC Genomics BioMed Central Methodology article Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach , 2008 .
[38] E. Estey,et al. RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis. , 2007, Cancer research.